Rating: MPX

Suitable for various B-cell malignancies, including mantle cell lymphoma, CLL, small lymphocytic lymphoma, and Waldenstroms macroglobulinemia, Ibrutinib uses
also extend to chronic graft vs. host disease post-systemic therapy failure.

https://www.thelotusbiotech.co....m/product/ibrunat-14